CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 54.18B
Enterprise value 33.34B
Trailing P/E 30.79
Forward P/E 123.68
PEG ratio (5-yr expected) 12.62
Price/sales (ttm)8.30
Price/book (mrq)2.47
Enterprise value/revenue 36.63
Enterprise value/EBITDA 617.59

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 318.76%
S&P500 52-week change 3-11.36%
52-week high 3119.44
52-week low 388.00
50-day moving average 3114.15
200-day moving average 3114.69

Share statistics

Avg vol (3-month) 3108.85k
Avg vol (10-day) 3114.35k
Shares outstanding 538.45M
Float 12.28M
% held by insiders 156.06%
% held by institutions 140.47%
Shares short (12 Mar 2020) 4403.06k
Short ratio (12 Mar 2020) 43.11
Short % of float (12 Mar 2020) 41.81%
Short % of shares outstanding (12 Mar 2020) 41.05%
Shares short (prior month 13 Feb 2020) 4382.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Dec 2019

Profitability

Profit margin 27.56%
Operating margin (ttm)32.49%

Management effectiveness

Return on assets (ttm)5.18%
Return on equity (ttm)9.03%

Income statement

Revenue (ttm)503.74M
Revenue per share (ttm)13.03
Quarterly revenue growth (yoy)-11.10%
Gross profit (ttm)329.08M
EBITDA 189.89M
Net income avi to common (ttm)137.12M
Diluted EPS (ttm)3.53
Quarterly earnings growth (yoy)-64.30%

Balance sheet

Total cash (mrq)927.26M
Total cash per share (mrq)24.1
Total debt (mrq)5.54M
Total debt/equity (mrq)0.31
Current ratio (mrq)10.89
Book value per share (mrq)44.09

Cash flow statement

Operating cash flow (ttm)229.34M
Levered free cash flow (ttm)158.44M